OmniAb (OABI) Invested Capital (2021 - 2026)
OmniAb (OABI) posted quarterly Invested Capital of $1.0 million for Q1 2026, up 183.85% year-over-year from $353000.0 in Q1 2025, and down 4.02% quarter-over-quarter from $1.0 million in Q4 2025.
Analysis
OmniAb (OABI) Invested Capital (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Invested Capital for 6 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital rose 183.85% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $3.9 million (up 125.78% YoY), while the FY2025 annual figure was $1.0 million, up 96.61% from the prior year.
- Invested Capital eased to $1.0 million in Q1 2026 per OABI's latest filing, from $1.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $4.0 million in Q4 2022 and bottomed at $42631.0 in Q1 2022.
- Historically, Invested Capital has averaged $1.1 million across 5 years, with a median of $891000.0 in 2024.
- Annual changes were most pronounced in 2022 — Invested Capital soared 1153220.0% — and 2024, when it tumbled 88.33%.
- OmniAb's Invested Capital stood at $4.0 million in 2022, then sank by 67.6% to $1.3 million in 2023, then slumped by 59.25% to $531000.0 in 2024, then soared by 96.61% to $1.0 million in 2025, then decreased by 4.02% to $1.0 million in 2026.
- Business Quant data shows OABI's Invested Capital at $1.0 million in Q1 2026, $1.0 million in Q4 2025, and $719000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 1.30 Bn |
| 10 | OmniAb | 576.36 Mn | 524.36 Mn | 12.81 Mn | 261.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 261.21 Mn |
| Mar 31, 2026 | 263.65 Mn |
| Dec 31, 2025 | 268.07 Mn |
| Sep 30, 2025 | 278.16 Mn |
| Jun 30, 2025 | 263.19 Mn |
| Mar 31, 2025 | 273.87 Mn |
| Dec 31, 2024 | 288.15 Mn |
| Sep 30, 2024 | 292.24 Mn |
| Jun 30, 2024 | 294.51 Mn |
| Mar 31, 2024 | 302.28 Mn |
| Dec 31, 2023 | 315.89 Mn |
| Sep 30, 2023 | 1.00 Bn |
| Jun 30, 2023 | 336.62 Mn |
| Mar 31, 2023 | 343.27 Mn |
| Dec 31, 2022 | 345.40 Mn |
| Sep 30, 2022 | 232.80 Mn |
| Jun 30, 2022 | 227.00 Mn |
| Mar 31, 2022 | 224.96 Mn |
| Dec 31, 2021 | 236.85 Mn |
| Jun 30, 2021 | 15,034.00 |